Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Benitec Biopharma (BNTC) Shares Outstanding (Diluted Average) (2021 - 2025)

Benitec Biopharma (BNTC) has disclosed Shares Outstanding (Diluted Average) for 5 consecutive years, with $38.6 million as the latest value for Q1 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 111.13% to $38.6 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $38.6 million through Mar 2025, up 111.13% year-over-year, with the annual reading at $18.4 million for FY2024, 1225.17% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $38.6 million in Q1 2025 for Benitec Biopharma, up from $32.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $38.6 million in Q1 2025 to a low of $480688.0 in Q2 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $10.9 million across 5 years, with a median of $6.2 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): crashed 92.19% in 2022 and later surged 1225.17% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $8.2 million in 2021, then crashed by 86.17% to $1.1 million in 2022, then soared by 128.01% to $2.6 million in 2023, then surged by 1164.35% to $32.6 million in 2024, then grew by 18.5% to $38.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for BNTC at $38.6 million in Q1 2025, $32.6 million in Q4 2024, and $27.9 million in Q3 2024.